In several malignant tumors, such as colorectal cancer, ovarian cancer, and hepatocellular carcinoma, high POSTN expression was confirmed to be associated with poor prognosis (Lv et al., 2013; Sung et al., 2016; Deng et al., 2019). This evidence concerns the gene POSTN and ovarian cancer.